Norbert Bischofberger

Norbert Bischofberger, Ph.D., is a Co-Founder and board member at Rezo. He is also the President and Chief Executive Officer of Kronos Bio. Previously, Norbert was the Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences. During his 28-year tenure at Gilead, Norbert presided over the development and approval of more than 25 medicines for a range of serious conditions which led the transformation of the treatment of diseases such as HIV, HCV and lymphoma. Norbert was part of the core management team that grew Gilead from less than 50 employees with no revenues to 10,000 employees with $25B in revenue. Norbert received a Ph.D. in organic chemistry from Zurich’s Eidgenössische Technische Hochschule, an honorary doctorate in Natural Sciences from The University of Innsbruck, and an honorary doctorate in Letters in Medicine from Baylor College of Medicine.